Ming Yan - Jul 22, 2021 Form 3 Insider Report for Cytek BioSciences, Inc. (CTKB)

Role
Chief Technology Officer, Director
Signature
/s/ Valerie Barnett, Attorney-in-Fact for Ming Yan
Stock symbol
CTKB
Transactions as of
Jul 22, 2021
Transactions value $
$0
Form type
3
Date filed
7/22/2021, 08:59 PM
Next filing
Feb 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CTKB Common Stock 8.14M Jul 22, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CTKB Stock Option (Right to Buy) Jul 22, 2021 Common Stock 62.5K $0.25 Direct
holding CTKB Stock Option (Right to Buy) Jul 22, 2021 Common Stock 26.7K $0.92 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option vest as follows: 25% of the shares subject to the option vests on July 24, 2021; and 1/48th of the shares subject to the option vest monthly thereafter over the following three years.

Remarks:

Exhibit 24 - Power of Attorney